Report of the 2024–2025 Strategic Engagement Committee

IF 3.5 4区 教育学 Q1 EDUCATION, SCIENTIFIC DISCIPLINES
Richard Silvia , Katherine S. O’Neal , Matthew M. Lacroix , Kristy Lucas , Haley J. McKeefer , Laura C. Palombi , Julie M. Sease , Hoai-An Truong , Elizabeth J. Unni , Olunife Akinmolayan , Terri Moore
{"title":"Report of the 2024–2025 Strategic Engagement Committee","authors":"Richard Silvia ,&nbsp;Katherine S. O’Neal ,&nbsp;Matthew M. Lacroix ,&nbsp;Kristy Lucas ,&nbsp;Haley J. McKeefer ,&nbsp;Laura C. Palombi ,&nbsp;Julie M. Sease ,&nbsp;Hoai-An Truong ,&nbsp;Elizabeth J. Unni ,&nbsp;Olunife Akinmolayan ,&nbsp;Terri Moore","doi":"10.1016/j.ajpe.2025.101463","DOIUrl":null,"url":null,"abstract":"<div><div>The American Association of Colleges of Pharmacy (AACP) has long prioritized strategic engagement, recognizing the important role it plays in the fulfillment of institutional missions, the success of pharmacy education, the advancement of pharmacy and public health practice, and the meeting of programmatic needs. The 2024–2025 Strategic Engagement Committee (SEC) was charged to compile a catalog of best practices for state-level advocacy activities that leverage the influence of colleges of pharmacy, state boards of pharmacy, and state pharmacy associations in collaboration with Advocacy Champions. The 2024–2025 SEC was also charged with developing a tactical agenda for AACP and member institutions to increase the engagement of student pharmacists in professional, regulatory, and legislative advocacy, including a catalog of best practices for teaching advocacy skills to student pharmacists. Both charges were informed by the work of the 2023–2024 SEC, which conducted focus groups with Advocacy Champions at the 2024 AACP Annual Meeting as part of its charges.</div></div>","PeriodicalId":55530,"journal":{"name":"American Journal of Pharmaceutical Education","volume":"89 9","pages":"Article 101463"},"PeriodicalIF":3.5000,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Pharmaceutical Education","FirstCategoryId":"95","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0002945925001081","RegionNum":4,"RegionCategory":"教育学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"EDUCATION, SCIENTIFIC DISCIPLINES","Score":null,"Total":0}
引用次数: 0

Abstract

The American Association of Colleges of Pharmacy (AACP) has long prioritized strategic engagement, recognizing the important role it plays in the fulfillment of institutional missions, the success of pharmacy education, the advancement of pharmacy and public health practice, and the meeting of programmatic needs. The 2024–2025 Strategic Engagement Committee (SEC) was charged to compile a catalog of best practices for state-level advocacy activities that leverage the influence of colleges of pharmacy, state boards of pharmacy, and state pharmacy associations in collaboration with Advocacy Champions. The 2024–2025 SEC was also charged with developing a tactical agenda for AACP and member institutions to increase the engagement of student pharmacists in professional, regulatory, and legislative advocacy, including a catalog of best practices for teaching advocacy skills to student pharmacists. Both charges were informed by the work of the 2023–2024 SEC, which conducted focus groups with Advocacy Champions at the 2024 AACP Annual Meeting as part of its charges.
2024-2025年战略接触委员会报告。
美国药学院协会(AACP)长期以来一直优先考虑战略参与,认识到它在履行机构使命、药学教育的成功、药学和公共卫生实践的进步以及满足规划需求方面发挥的重要作用。2024-2025年战略参与委员会(SEC)负责编制一份州级宣传活动的最佳实践目录,这些活动利用药学院、州药事委员会和州药事协会与倡导冠军组织合作的影响力。2024-2025年SEC还负责为AACP和成员机构制定战术议程,以提高学生药剂师在专业、监管和立法倡导方面的参与度,包括向学生药剂师教授倡导技能的最佳实践目录。这两项指控都是由2023-2024年美国证券交易委员会的工作提供的,该委员会在2024年aacp年会上与倡导倡导者进行了焦点小组讨论,作为其指控的一部分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.30
自引率
15.20%
发文量
114
期刊介绍: The Journal accepts unsolicited manuscripts that have not been published and are not under consideration for publication elsewhere. The Journal only considers material related to pharmaceutical education for publication. Authors must prepare manuscripts to conform to the Journal style (Author Instructions). All manuscripts are subject to peer review and approval by the editor prior to acceptance for publication. Reviewers are assigned by the editor with the advice of the editorial board as needed. Manuscripts are submitted and processed online (Submit a Manuscript) using Editorial Manager, an online manuscript tracking system that facilitates communication between the editorial office, editor, associate editors, reviewers, and authors. After a manuscript is accepted, it is scheduled for publication in an upcoming issue of the Journal. All manuscripts are formatted and copyedited, and returned to the author for review and approval of the changes. Approximately 2 weeks prior to publication, the author receives an electronic proof of the article for final review and approval. Authors are not assessed page charges for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信